MT MPJE key terms

The state agency that licenses pharmacists and pharmacies, adopts rules under the state pharmacy practice act, inspects facilities, and disciplines licensees. Its authority is separate from federal agencies such as the FDA or DEA.

The statutorily defined scope of activities reserved to licensed pharmacists, typically including dispensing, compounding, patient counseling, drug regimen review, and collaborative drug therapy management. Activities outside the definition may require a different license or be prohibited.

The process by which a pharmacist licensed in one state obtains licensure in another, usually through score transfer or license verification rather than re-examination. Most states require the license to be in good standing and may require additional state-specific exams.

The periodic credit hours a licensee must complete to renew licensure, often including mandated topic hours such as law, patient safety, or opioid prescribing. Credits generally must come from accredited providers and be documented for audit.

The recurring process of maintaining an active license by paying fees, reporting continuing education, and disclosing any disciplinary or criminal history. Practicing on an expired or lapsed license is generally unlawful and may carry separate penalties.

The act of preparing and transferring a drug pursuant to a valid prescription, including verifying the order, filling, labeling, and recordkeeping. State law defines who may dispense and under what supervision pharmacy technicians may participate.

The final professional check by a pharmacist confirming that a prepared prescription is accurate and clinically appropriate before it reaches the patient. Many states require this step even when technicians perform most of the filling process.

A state-set limit on how many technicians or assistants one pharmacist may supervise at a given time, sometimes tiered by task or setting. Exceeding the ratio can expose the pharmacy to discipline even if no error occurs.

The documentation a pharmacy must retain for each dispensed prescription, typically including patient, prescriber, drug, quantity, date, and dispensing pharmacist. States set retention periods, often two years or longer, and require records be readily retrievable.

State-mandated content that must appear on a prescription container, such as pharmacy identity, patient name, directions, date, and cautionary statements. States may add requirements beyond federal labeling rules, including auxiliary and language-access instructions.

The offer of verbal information about a new or changed prescription, covering proper use, storage, and significant risks. States specify who may counsel, when it must be offered, and when documented refusal permits dispensing without it.

A written arrangement allowing a pharmacist to manage drug therapy under a defined protocol with one or more prescribers, including initiation or adjustment of medications. Scope, reporting, and patient eligibility are set by state law.

The legal power to authorize drug therapy, which may be granted to pharmacists in limited forms such as protocol-based, emergency, or self-administered contraceptive prescribing. The authority is always bounded by state statute and board rules.

A state-authorized mechanism permitting a pharmacist to dispense a limited supply of a chronic medication when a prescriber cannot be reached. Duration limits, drug exclusions, and documentation duties vary by state.

The requirement to reach the prescriber to clarify or validate an ambiguous, incomplete, or suspect prescription before dispensing. States and boards treat undocumented clarification as a dispensing error risk.

Preparing a customized medication from ingredients or manipulating a manufactured product to meet an individual patient need. State rules cover equipment, training, beyond-use dating, and when a prescription or prescriber authorization is needed.

Compounding quality standards such as USP <795>, <797>, and <800> that states often adopt by reference for nonsterile, sterile, and hazardous drug handling. Adoption status and any state modifications matter for compliance.

Requirements for receiving, storing, preparing, dispensing, and disposing of drugs on a hazardous list, emphasizing containment and worker protection. States may enforce these through board inspection rules or adopt federal and USP standards.

The documentation of drug stock, including receipts, disbursements, and periodic counts, used to support accountability and controlled substance reconciliation. States may impose additional recordkeeping for certain drugs or devices.

State rules governing whether dispensed drugs may be returned to stock, how expired or unused drugs are destroyed, and who may witness destruction. Reverse distributor and collection-site rules often interact with federal controlled substance requirements.

Remote provision of pharmacy services, such as verification or counseling, using technology to connect a pharmacist to a distant site. States differ on whether it is permitted, what supervision is required, and whether a site must be separately licensed.

State and federal rules governing pharmacies that dispense through websites or mail, including licensure where patients reside and prohibitions on dispensing without a valid prescription. Nonresident pharmacy registration is commonly required.

A pharmacy located outside the state that ships or mails drugs to patients within it. Most states require registration, a designated in-state agent, and compliance with the patient's home-state labeling and counseling rules.

A state-affiliated or board-approved program allowing licensees with substance use or mental health conditions to seek monitoring and treatment, often in lieu of discipline. Confidentiality, self-reporting duties, and eligibility rules vary.

The enumerated acts that can lead to license suspension, revocation, or reprimand, such as fraud, practicing below the standard of care, or unprofessional conduct. Boards may also impose probation, fines, or remediation.

An order issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice, with all required elements present. A prescription lacking essential elements or obtained by fraud is not valid.

The pharmacist's federal duty to refuse to fill a controlled substance prescription that is not issued for a legitimate medical purpose or in the usual course of practice. It applies even when the prescription is technically complete.

Warning signs suggesting a controlled substance prescription may be improper, such as long distances, cash payment, early refills, or inconsistent directions. Pharmacists must resolve red flags before dispensing to satisfy corresponding responsibility.

The federal DEA registration required to manufacture, distribute, dispense, or conduct research with controlled substances, plus any separate state controlled substance license. Both must generally be active and at the registered location.

Federal limits on Schedule II prescribing, including no refills, a maximum 90-day supply per prescription, and specific requirements for multiple prescriptions and emergency oral orders. States may impose stricter limits.

Dispensing less than the full quantity prescribed, with rules on how much time remains to supply the balance. Federal rules permit partial fills of Schedule II prescriptions in defined cases, and states may add requirements.

The federal requirement to take a complete inventory of controlled substances every two years, including counts, records, and signature. Newly registered registrants must take an initial inventory on the date they begin business.

The DEA order forms, paper or electronic, used to transfer Schedule I and II controlled substances between registrants. Power of attorney and secure electronic credentialing rules govern who may sign orders.

Federal duties to maintain records of controlled substance transactions and to report theft, significant loss, or suspicious orders to DEA. Records must generally be kept for two years and be available for inspection.

Limits on how often and how long a prescription may be refilled, and conditions for transferring prescriptions between pharmacies. Schedule III-V refills are capped and expire, while Schedule II prescriptions cannot be refilled.

Drug utilization review screens prescriptions for safety problems, while prescription drug monitoring programs are state databases tracking controlled substance dispensing. Pharmacists generally must query the PDMP in defined circumstances before dispensing.

The federal framework under which drugs are approved for marketing and must carry approved labeling, including prescription status and warnings. Pharmacists must follow federal labeling and any risk management requirements attached to the product.

A FDA-required safety program, sometimes with restricted distribution or certification, imposed on certain high-risk drugs. Pharmacies and pharmacists may need to enroll and verify patient or prescriber status before dispensing.

Federal restrictions on retail sale of scheduled listed chemical products, including daily and monthly purchase limits, logbook requirements, and identification checks. Sellers must also provide required training and self-certify with DEA.